this is a follow up to an earlier article on this research this article in neurology advisor has an important message for your doctor patients with spinal bulbar muscular atrophy sbma are at high risk for nonalcoholic liver disease as well as elevated glucose , serum triglycerides , and insulin , according to study findings published in neurology although the researchers indicate that previous research has demonstrated elevations of serum cholesterol in patients with sbma , the small sample size of in the second group limits the study 's detection power for this variable because of the liver 's prominent role in drug metabolism , the investigators suggest healthcare practitioners prescribing medications or evaluating candidate therapeutics for patients with sbma should be aware of the risk for fatty liver disease and monitor hepatic function